Latest Earnings Results: Q2 '26
Estimated EPS
-$0.57
Reported EPS
-$0.85
Surprise
-49.78%
Estimated Rev
$0.42M
Reported Rev
$0.4M
Surprise
-4%
VolitionRx Limited reported total revenues of $0.4 million for the three months ended June 30, 2026, and $1.4 million for the six months ended June 30, 2026, reflecting ongoing commercialization activities.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.38 | -- | -- | N/A |
Q2 '26 | -$0.57 | -$0.85 | -49.78% | MISSED |
Q1 '26 | -$0.73 | -$0.97 | -32.88% | MISSED |
Q4 '25 | -$0.04 | -- | -- | N/A |
Q3 '25 | -$0.04 | -$0.05 | -13.64% | MISSED |